m.salgado
Submits third-party assay reports on material purchased directly. Based in Monterrey.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
98.60%
n=6
Suppliers covered
6
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042476 | Melanotan II | SWB | SWB-2603-A5707 | VendorInvestigate | 2026-Q3 | 98.25 | 3.86 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-043449 | BPC-157 | WXT | WXT-2602-W4680 | Janoshik | 2026-Q2 | 98.12 | 5.60 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042524 | Liraglutide | ERP | ERP-2601-P6802 | Janoshik | 2026-Q2 | 98.81 | 5.09 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020117 | Tirzepatide | GGPeps | GGPE-2502-J8885 | Janoshik | 2025-Q3 | 98.58 | 5.63 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019428 | Semaglutide | Homopeptide | HOMO-2506-V8763 | PeptideMeter | 2025-Q3 | 98.62 | 5.10 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018478 | Tirzepatide | WWB | WWB-2502-U2990 | Janoshik | 2025-Q1 | 99.10 | 2.73 | 97.4 | Supplier-supplied | 1 | MARGINAL |